Navigation Links
China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
Date:11/20/2008

BEIJING, Nov. 20 /PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it has successfully completed the development of two proprietary molecular diagnostic kits for the detection of epidermal growth factor receptor ("EGFR") abnormalities in patients with non-small cell lung cancer ("NSCLC"). The Company expects to offer the kits to its hospital customers through its direct sales force in January 2009.

Currently, Iressa and Tarceva are commonly used drugs for the treatment of patients with NSCLC. These drugs target the EGFR gene located at 7p12. According to publications in medical journals, EGFR abnormalities have been found in approximately 85% of NSCLC patients responsive to Iressa and Tarceva. Some of these abnormalities could be identified by using FISH-based technique to detect increase in gene copy numbers; others could be detected by using real-time PCR-based technique to analyze EGFR gene mutations. The Company has successfully completed the development of both FISH and real-time PCR-based molecular diagnostic kits for detecting EGFR abnormalities. The test result provides guidance for physicians to determine the most appropriate therapy for patients with NSCLC.

"We are excited about the successful development of molecular diagnostic kits for non-small cell lung cancer therapy," said Mr. Xiaodong Wu, Chairman and CEO of the Company. "We will continue to leverage our molecular diagnostic technology platforms to develop more products with significant market potential."

Lung cancer is one of the most common cancers in the world and it is the leading cause of cancer death in China. It is estimated that more than 500,000
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
2. China Biologic Products Reports Strong Third Quarter 2008 Results
3. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
4. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
5. China Biologic Products Announces Third Quarter 2008 Results Conference Call
6. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
7. China Clean Energy Resumes Biodiesel Production After Temporary Halt
8. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
11. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... endpoint Clinical ( www.endpointclinical.com ), a ... (IWR) systems, announced today that PULSE, a fully ... deploy clinical trial Integrated Response Technology (IRT) systems, ... clinical trials. This time and cost savings stems ... developers do not have to spend valuable time ...
(Date:2/9/2010)... A leading clinical research center in ... study an investigational drug designed as a possible treatment ... affects between 45 and 90 percent of women of ... not life threatening, dysmenorrhea can be debilitating and psychologically ... absenteeism from work and school. ,, Current therapies for ...
(Date:2/9/2010)... and AMSTERDAM , February 9 ... cancer diagnostics, announced today that,it has received the ... State ,Department of Health. The New York ... samples of MammaPrint, its FDA-cleared breast cancer recurrence,test. ... permit, Agendia has now obtained all major U.S. ...
(Date:2/9/2010)... Belgium , February 9 ... the Potential of Microplasmin to Improve the Treatment,of ... ,, ThromboGenics NV (Euronext ... and development of innovative treatments for eye,disease, vascular ... Phase II trial results, evaluating the product,s efficacy ...
Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2endpoint Saves Money and Time for Medical Research Teams Through PULSE 3Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps 2Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4
... Nov. 26 Evalve, Inc., the leader in,the ... cardiac valves,announced today that the first three patients ... the University of Hull, Castle Hill Hospital,in the ... commercially,available medical device which provides a non-surgical mitral ...
... an update on internal policy and clinical, ... Symbol: RVX , , CALGARY, ... that the previously announced internal blackout trading restriction of April ... regional and global partnerships are actively ongoing and should the ...
... Nov. 26 Thomas K. Equels, President and Managing,Director ... the board of directors,for Hemispherx BioPharma, Inc. (Amex: ... manufacture and clinical development,of new drug entities for the ... Equels, legal practice is devoted ...
Other Biology Technology:First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 2First United Kingdom Patients Treated With Percutaneous MitraClip(R) System 3Resverlogix Board of Directors Update 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3
(Date:2/9/2010)... majority owned subsidiary of Avisio, Inc. acquired an ... , The technology is based on an ... e.g. mosquitos and black flies, utilize their olfactory ... animals and humans. CO2, which is a major ... insect to its prey. , Developed by ...
(Date:2/8/2010)... Mediterranean diet may help people avoid the small areas ... thinking and memory, according to a study released today ... Neurology,s 62nd Annual Meeting in Toronto April 10 to ... people who ate a Mediterranean-like diet were less likely ... tissue linked to thinking problems. , The Mediterranean ...
(Date:2/8/2010)... With the recent election of Senator ... in the loss of the Democratic supermajority, the urgency ... universal coverage for the majority of uninsured Americans has ...  President Obama recently noted the country is closer than ... for many a long sought after social reform, and ...
Breaking Biology News(10 mins):Mediterranean diet may lower risk of brain damage that causes thinking problems 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County 53506 1Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County 53506 2Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 1Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 2Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 3Hard to Treat Diseases Inc 28HTDS 29 Experiments with Hyperbaric Oxygenation 28HBO 29 Traumatic Brain Injury 53504 4Exercise Is Healthy for Mom and Child During Pregnancy 53502 1Exercise Is Healthy for Mom and Child During Pregnancy 53502 2Exercise Is Healthy for Mom and Child During Pregnancy 53502 3
... reported findings that offer a surprising new twist to ... select the flowers from which they collect nectar. When ... flowers entirely alone but instead copy the choices of ... their behavior when dealing with flowers of unfamiliar plant ...
... paths some 5 million to 6 million years ago, we ... and acquired a knack for abstract thought while our next ... to construct tree-bound nests high above the forest floor. We ... sequence level, yet scientists predict that both species should harbor ...
... River varies in time, what causes those variations, and ... deforestation is a focus of study for scientists at ... in the last several decades have led to significant ... eastern and southern portion of the basin. By using ...
Other Biology News:Can our genes tell the story of our divergence? 2Assessing the Amazon River's sensitivity to deforestation 2
... II xi 2-D system runs both gel dimensions in ... gels can be separated in a single run using ... core in much the same manner as the slab ... second-dimension slab gels may be cast in the casting ...
... Experion StdSens analysis kit for 25 chips ... perform standard-sensitivity RNA analysis (at nanogram levels) ... kit includes 25 RNA StdSens microfluidic chips, ... x 20 microliters RNA StdSens stain, 2 ...
... Rotator, variable speed, timer, SB3, Fully adjustable ... of tube holders to hold a number ... SB3 is ideal for aerating cultures, keeping ... mixing applications., The rotator can be used ...
...
Biology Products: